IS5062A - Lyfjablöndur sem innihalda afleiður N-súlfonýlindólíns - Google Patents
Lyfjablöndur sem innihalda afleiður N-súlfonýlindólínsInfo
- Publication number
- IS5062A IS5062A IS5062A IS5062A IS5062A IS 5062 A IS5062 A IS 5062A IS 5062 A IS5062 A IS 5062A IS 5062 A IS5062 A IS 5062A IS 5062 A IS5062 A IS 5062A
- Authority
- IS
- Iceland
- Prior art keywords
- preparations containing
- medicinal preparations
- sulfonylindoline
- derivatives
- sulfonylindoline derivatives
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9614957A FR2756736B1 (fr) | 1996-12-05 | 1996-12-05 | Compositions pharmaceutiques contenant des derives de n-sulfonyl indoline |
PCT/FR1997/002210 WO1998024430A1 (fr) | 1996-12-05 | 1997-12-04 | Compositions pharmaceutiques contenant des derives de n-sulfonyl indoline |
Publications (1)
Publication Number | Publication Date |
---|---|
IS5062A true IS5062A (is) | 1999-06-01 |
Family
ID=9498376
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IS5062A IS5062A (is) | 1996-12-05 | 1999-06-01 | Lyfjablöndur sem innihalda afleiður N-súlfonýlindólíns |
Country Status (25)
Country | Link |
---|---|
EP (1) | EP0941090A1 (is) |
JP (1) | JP2000507618A (is) |
KR (1) | KR20000069308A (is) |
CN (1) | CN1239887A (is) |
AR (1) | AR009651A1 (is) |
AU (1) | AU716575B2 (is) |
BR (1) | BR9712406A (is) |
CA (1) | CA2273990A1 (is) |
CO (1) | CO4910129A1 (is) |
DZ (1) | DZ2362A1 (is) |
EE (1) | EE9900206A (is) |
FR (1) | FR2756736B1 (is) |
HU (1) | HUP0001386A3 (is) |
ID (1) | ID23373A (is) |
IL (1) | IL129936A0 (is) |
IS (1) | IS5062A (is) |
MY (1) | MY132819A (is) |
NO (1) | NO992724L (is) |
NZ (1) | NZ335750A (is) |
RU (1) | RU2174394C2 (is) |
SK (1) | SK75599A3 (is) |
TR (1) | TR199901702T2 (is) |
WO (1) | WO1998024430A1 (is) |
YU (1) | YU23099A (is) |
ZA (1) | ZA9710919B (is) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2786486B3 (fr) * | 1998-11-16 | 2000-12-08 | Sanofi Sa | Procede de preparation du (2s)-1-[(2r,3s)-5-chloro-3-(2- chlorophenyl)-1-(3,4-dimethoxy benzenesulfonyl)-3-hydroxy- 2,3-dihydro-1h-indole-2-carbonyl]pyrrolidine-2-carboxamide, de ses solvats et/ou hydrates |
DE19913692A1 (de) * | 1999-03-25 | 2000-09-28 | Basf Ag | Mechanisch stabile pharmazeutische Darreichungsformen, enthaltend flüssige oder halbfeste oberflächenaktive Substanzen |
US6437006B1 (en) | 1999-09-27 | 2002-08-20 | American Cyanamid Company | Pharmaceutical carrier formulation |
WO2001034119A2 (en) | 1999-11-12 | 2001-05-17 | Abbott Laboratories | Inhibitors of crystallization in a solid dispersion |
FR2805992A1 (fr) * | 2000-03-08 | 2001-09-14 | Sanofi Synthelabo | Compositions pharmaceutiques orales contenant des derives de n-sulfonylindoline |
DE10026698A1 (de) | 2000-05-30 | 2001-12-06 | Basf Ag | Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung |
ITMI20011338A1 (it) | 2001-06-26 | 2002-12-26 | Farmatron Ltd | Composizioni farmaceutiche orali a rilascio immediato del principio attivo |
US8025899B2 (en) | 2003-08-28 | 2011-09-27 | Abbott Laboratories | Solid pharmaceutical dosage form |
UA119324C2 (uk) * | 2013-04-02 | 2019-06-10 | Теміс Медікер Лімітед | Композиції фармацевтично активних речовин, що містять моноетиловий ефір діетиленгліколю або інші алкільні похідні |
KR102139338B1 (ko) * | 2013-06-24 | 2020-07-29 | 주식회사 엘지생활건강 | 인돌 화합물을 포함하는 용해도가 개선된 화장료 조성물 |
KR102139339B1 (ko) * | 2013-06-24 | 2020-07-29 | 주식회사 엘지생활건강 | 인돌 화합물을 포함하는 용해도가 개선된 화장료 조성물 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3237814A1 (de) * | 1982-10-12 | 1984-04-12 | Warner-Lambert Co., 07950 Morris Plains, N.J. | Wasserfreie emulsionen und verwendung derselben |
FR2679903B1 (fr) * | 1991-08-02 | 1993-12-03 | Elf Sanofi | Derives de la n-sulfonyl indoline portant une fonction amidique, leur preparation, les compositions pharmaceutiques en contenant. |
-
1996
- 1996-12-05 FR FR9614957A patent/FR2756736B1/fr not_active Expired - Fee Related
-
1997
- 1997-12-03 DZ DZ970212A patent/DZ2362A1/xx active
- 1997-12-04 CA CA002273990A patent/CA2273990A1/fr not_active Abandoned
- 1997-12-04 EE EEP199900206A patent/EE9900206A/xx unknown
- 1997-12-04 EP EP97950228A patent/EP0941090A1/fr not_active Withdrawn
- 1997-12-04 ID IDW990445D patent/ID23373A/id unknown
- 1997-12-04 CO CO97071118A patent/CO4910129A1/es unknown
- 1997-12-04 ZA ZA9710919A patent/ZA9710919B/xx unknown
- 1997-12-04 BR BR9712406-0A patent/BR9712406A/pt unknown
- 1997-12-04 RU RU99114019/14A patent/RU2174394C2/ru active
- 1997-12-04 CN CN97180304A patent/CN1239887A/zh active Pending
- 1997-12-04 IL IL12993697A patent/IL129936A0/xx unknown
- 1997-12-04 AR ARP970105696A patent/AR009651A1/es unknown
- 1997-12-04 NZ NZ335750A patent/NZ335750A/en unknown
- 1997-12-04 WO PCT/FR1997/002210 patent/WO1998024430A1/fr not_active Application Discontinuation
- 1997-12-04 HU HU0001386A patent/HUP0001386A3/hu unknown
- 1997-12-04 MY MYPI97005848A patent/MY132819A/en unknown
- 1997-12-04 AU AU53262/98A patent/AU716575B2/en not_active Ceased
- 1997-12-04 JP JP10525294A patent/JP2000507618A/ja active Pending
- 1997-12-04 KR KR1019997004983A patent/KR20000069308A/ko not_active Application Discontinuation
- 1997-12-04 TR TR1999/01702T patent/TR199901702T2/xx unknown
- 1997-12-04 SK SK755-99A patent/SK75599A3/sk unknown
-
1999
- 1999-05-26 YU YU23099A patent/YU23099A/sr unknown
- 1999-06-01 IS IS5062A patent/IS5062A/is unknown
- 1999-06-04 NO NO992724A patent/NO992724L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU716575B2 (en) | 2000-03-02 |
NO992724D0 (no) | 1999-06-04 |
ZA9710919B (en) | 1999-06-04 |
EP0941090A1 (fr) | 1999-09-15 |
FR2756736B1 (fr) | 1999-03-05 |
TR199901702T2 (en) | 1999-09-21 |
NZ335750A (en) | 2001-06-29 |
KR20000069308A (ko) | 2000-11-25 |
IL129936A0 (en) | 2000-02-29 |
YU23099A (en) | 1999-11-22 |
AU5326298A (en) | 1998-06-29 |
JP2000507618A (ja) | 2000-06-20 |
BR9712406A (pt) | 1999-08-31 |
CN1239887A (zh) | 1999-12-29 |
FR2756736A1 (fr) | 1998-06-12 |
EE9900206A (et) | 1999-12-15 |
AR009651A1 (es) | 2000-04-26 |
RU2174394C2 (ru) | 2001-10-10 |
MY132819A (en) | 2007-10-31 |
CA2273990A1 (fr) | 1998-06-11 |
SK75599A3 (en) | 2000-08-14 |
WO1998024430A1 (fr) | 1998-06-11 |
HUP0001386A2 (hu) | 2001-04-28 |
HUP0001386A3 (en) | 2002-03-28 |
ID23373A (id) | 2000-04-20 |
NO992724L (no) | 1999-06-04 |
DZ2362A1 (fr) | 2002-12-28 |
CO4910129A1 (es) | 2000-04-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE236617T1 (de) | Aerosol-arzneiformulierungen | |
NO974618D0 (no) | Farmasöytiske preparater for intranasal administrasjon | |
ATE304351T1 (de) | Arzneizubereitungen enthaltend kannabinoide | |
DE69518331D1 (de) | Orale zubereitungen | |
DE69708327D1 (de) | Pulverinhalator | |
DK0783302T3 (da) | Lægemidler | |
IL131319A0 (en) | 3-Piperidyl-4- oxoquinazoline derivatives and medicinal compositions containing the same | |
NO954486D0 (no) | Farmasöytiske formuleringsgrunnlag | |
ATE367150T1 (de) | Arzneimittel | |
NO995251D0 (no) | FremgangsmÕte for administrering av haloterapi | |
DE59707298D1 (de) | Desodorierende zubereitungen | |
IS5062A (is) | Lyfjablöndur sem innihalda afleiður N-súlfonýlindólíns | |
DE69700887D1 (de) | Isoprenderivate | |
ID16781A (id) | Formulasi-formulasi farmasi | |
DE69432149D1 (de) | Orale Zubereitungen | |
DK0925273T3 (da) | Farmaceutiske præparater indeholdende 4-oxo-butansyrer | |
ATE298576T1 (de) | Arzneizubereitungen | |
ITMI941169A0 (it) | Formulazioni farmaceutiche | |
DK0826679T3 (da) | Naphthylforbindelser og -præparater | |
ID18698A (id) | Komposisi farmasi | |
EE03511B1 (et) | Misolastiini sisaldavad prolongeeritud toimega farmatseutilised preparaadid | |
ATE237309T1 (de) | Arzneizubereitungen | |
EP1142589A4 (en) | MEDICAL COMPOSITIONS | |
FI951155A0 (fi) | Farmaseuttinen valmiste | |
ITMI962628A0 (it) | Composizione farmaceutica |